Ads
related to: nvax stock price today per share
Search results
Results From The WOW.Com Content Network
Novavax stock ( NVAX) is on a tear — soaring nearly 300% in the past month to $19.56 per share — following several pieces of good news. The Food and Drug Administration (FDA) today finally set ...
Novavax beat on earnings per share, at $1.08 versus consensus estimates of $1.05, but it missed on revenues, reporting $98.3 million compared to Wall Street expectations of more than $101 million.
Novavax is expected to post earnings of $2.34 per share for the current quarter, representing a year-over-year change of +154.3%. Over the last 30 days, the Zacks Consensus Estimate has changed -36%.
Novavax (NVAX) is down from a peak of $217.32 on Dec. 17 to just $53.69, reaching a new low. The company is still waiting for FDA approval of its Covid-19 vaccine, but the worst of the pandemic ...
Investors in Novavax (NASDAQ:NVAX) can’t catch a break — whether the news is positive or negative. One month ago, NVAX stock was trading for above $200 per share. Since then, it’s plummeted ...
Novavax, Inc. Novavax, Inc. is an American biotechnology company based in Gaithersburg, Maryland, that develops vaccines to counter serious infectious diseases. Prior to 2020, company scientists developed experimental vaccines for influenza and respiratory syncytial virus (RSV), as well as Ebola and other emerging infectious diseases. During ...
Popular vaccine player Novavax (NASDAQ:NVAX) has certainly been a volatile stock this week. In fact, NVAX stock has been a big mover over the past month, given a series of positive catalysts ...
Novavax (NVAX) was the coronavirus stock to hold last year, as the company punched far above its weight and delivered investors incredible returns. The small vaccine player took the good fight to ...